{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:10:41Z","timestamp":1793293841720,"version":"4.5.0"},"reference-count":178,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.humpath.2024.105676","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T06:44:27Z","timestamp":1729838667000},"page":"105676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Bridging clinicopathologic features and genetics in follicular lymphoma: Towards enhanced diagnostic accuracy and subtype differentiation"],"prefix":"10.1016","volume":"156","author":[{"given":"Jan","family":"Bosch-Schips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenia","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4360-8388","authenticated-orcid":false,"given":"Fina","family":"Climent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5956-452X","authenticated-orcid":false,"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.humpath.2024.105676_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3322\/caac.21357","article-title":"2016 US lymphoid malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2024.105676_bib116","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"22","key":"10.1016\/j.humpath.2024.105676_bib3","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","article-title":"Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease","volume":"4","author":"Nann","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.hoc.2020.02.001","article-title":"Epidemiology of follicular lymphoma","volume":"34","author":"Cerhan","year":"2020","journal-title":"Hematol Oncol Clin N Am"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/bjh.12659","article-title":"Differences in incidence and trends of haematological malignancies in Japan and the United States","volume":"164","author":"Chihara","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.envres.2009.09.011","article-title":"Residential proximity to industrial facilities and risk of non-Hodgkin lymphoma","volume":"110","author":"De Roos","year":"2010","journal-title":"Environ Res"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib7","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.3747\/co.26.4625","article-title":"Incidence and mortality trends and geographic patterns of follicular lymphoma in Canada","volume":"26","author":"Le","year":"2019","journal-title":"Curr Oncol"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/PAS.0b013e31818e6489","article-title":"Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin","volume":"33","author":"Weinberg","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"45","key":"10.1016\/j.humpath.2024.105676_bib9","doi-asserted-by":"crossref","first-page":"78410","DOI":"10.18632\/oncotarget.19240","article-title":"Sites of extranodal involvement are prognostic in patients with stage 1 follicular lymphoma","volume":"8","author":"Shastri","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.humpath.2024.105676_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.clml.2019.02.011","article-title":"Early stage extranodal follicular lymphoma: characteristics, management, and outcomes","volume":"19","author":"Andraos","year":"2019","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"issue":"3","key":"10.1016\/j.humpath.2024.105676_bib11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.annonc.2020.11.008","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Dreyling","year":"2021","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.humpath.2024.105676_bib12","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1200\/JCO.2014.59.7534","article-title":"Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the national LymphoCare study","volume":"33","author":"Casulo","year":"2015","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105676_bib13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ccell.2024.02.001","article-title":"Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients","volume":"42","author":"Radtke","year":"2024","journal-title":"Cancer Cell"},{"issue":"18","key":"10.1016\/j.humpath.2024.105676_bib14","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/0006-2952(89)90010-5","article-title":"Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumor cells","volume":"38","author":"Sehested","year":"1989","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.humpath.2024.105676_bib15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41375-018-0043-y","article-title":"Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma","volume":"32","author":"Araf","year":"2018","journal-title":"Leukemia"},{"issue":"21","key":"10.1016\/j.humpath.2024.105676_bib16","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1182\/blood.2020009855","article-title":"Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma","volume":"137","author":"Haebe","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.envres.2009.09.011","article-title":"Residential proximity to industrial facilities and risk of non-Hodgkin lymphoma","volume":"110","author":"De Roos","year":"2010","journal-title":"Environ Res"},{"key":"10.1016\/j.humpath.2024.105676_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.envint.2019.03.018","article-title":"Non-Hodgkin lymphoma risk and organophosphate and carbamate insecticide use in the north American pooled project","volume":"127","author":"Koutros","year":"2019","journal-title":"Environ Int"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib19","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.3390\/ijerph110404449","article-title":"Non-Hodgkin lymphoma and occupational exposure to agricultural pesticide chemical groups and active ingredients: a systematic review and meta-analysis","volume":"11","author":"Schinasi","year":"2014","journal-title":"Int J Environ Res Publ Health"},{"issue":"48","key":"10.1016\/j.humpath.2024.105676_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jncimonographs\/lgu006","article-title":"Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Linet","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"6","key":"10.1016\/j.humpath.2024.105676_bib21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10552-007-9013-9","article-title":"Obesity and risk of non-Hodgkin lymphoma (United States)","volume":"18","author":"Chiu","year":"2007","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2141.2009.07721.x","article-title":"Highly increased familial risks for specific lymphoma subtypes","volume":"146","author":"Goldin","year":"2009","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105676_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/leu.2015.272","article-title":"Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries","volume":"30","author":"Fallah","year":"2016","journal-title":"Leukemia"},{"issue":"4706","key":"10.1016\/j.humpath.2024.105676_bib24","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.3874430","article-title":"Involvement of the bcl-2 gene in human follicular lymphoma","volume":"228","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.humpath.2024.105676_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00428-015-1864-y","article-title":"The heterogeneity of follicular lymphomas: from early development to transformation","volume":"468","author":"Xerri","year":"2016","journal-title":"Virchows Arch"},{"issue":"18","key":"10.1016\/j.humpath.2024.105676_bib26","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood-2015-06-649905","article-title":"Cell of origin of transformed follicular lymphoma","volume":"126","author":"Kridel","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.humpath.2024.105676_bib27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9440(10)63313-5","article-title":"Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component","volume":"165","author":"Katzenberger","year":"2004","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.humpath.2024.105676_bib28","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1084\/jem.20061292","article-title":"Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis [published correction appears in J Exp Med. 2006 Oct 30;203(11):2563]","volume":"203","author":"Roulland","year":"2006","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.humpath.2024.105676_bib29","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1200\/JCO.2001.19.2.420","article-title":"Frequency of the Bcl-2\/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma","volume":"19","author":"Summers","year":"2001","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.humpath.2024.105676_bib30","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6","key":"10.1016\/j.humpath.2024.105676_bib31","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/2159-8290.CD-23-0111","article-title":"Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors","volume":"13","author":"Schroers-Martin","year":"2023","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib32","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1038\/s41467-024-47012-1","article-title":"Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment","volume":"15","author":"Li","year":"2024","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.humpath.2024.105676_bib33","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ccell.2020.04.004","article-title":"Mutant EZH2 induces a pre-malignant lymphoma niche by reprogramming the immune response","volume":"37","author":"B\u00e9guelin","year":"2020","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-18-1090","article-title":"Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition","volume":"9","author":"Ennishi","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.humpath.2024.105676_bib35","doi-asserted-by":"crossref","unstructured":"Santos Louro L, Dimopoulos Y, Leventaki V, Vega F. Follicular lymphoma of the lower female genital tract: an indolent and localized extranodal follicular lymphoma with mutation of TNFRSF14. Leuk Lymphoma.Published online July 21, 2024. doi:10.1080\/10428194.2024.","DOI":"10.1080\/10428194.2024.2381014"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.humpath.2024.105676_bib1","series-title":"WHO classification of tumors hematopoietic and lymphoid tissues","author":"Campo","year":"2017"},{"issue":"3","key":"10.1016\/j.humpath.2024.105676_bib37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/his.12753","article-title":"The relationship between overt and in-situ lymphoma: a retrospective study of follicular and mantle cell lymphoma cases","volume":"68","author":"Teixeira Mendes","year":"2016","journal-title":"Histopathology."},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3109\/10428194.2011.624229","article-title":"In situ follicular lymphoma associated with nonlymphoid malignancies","volume":"53","author":"Carbone","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2559.2011.03897.x","article-title":"Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes","volume":"59","author":"Henopp","year":"2011","journal-title":"Histopathology."},{"issue":"5","key":"10.1016\/j.humpath.2024.105676_bib40","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/his.14617","article-title":"Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort","volume":"80","author":"Oishi","year":"2022","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.humpath.2024.105676_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000449253","article-title":"Lymphadenectomy specimens in a large retrospective cohort of pediatric patients reveal No in situ lymphomas but a broad spectrum of reactive changes","volume":"84","author":"Banz","year":"2017","journal-title":"Pathobiology"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V98.1.238","article-title":"Variable heavy-chain gene analysis of follicular lymphomas: subclone selection rather than clonal evolution over time","volume":"98","author":"Aarts","year":"2001","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.humpath.2024.105676_bib43","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/01.pas.0000173233.29741.38","article-title":"Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage","volume":"29","author":"Adam","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2024.105676_bib44","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood.V99.9.3376","article-title":"In situ localization of follicular lymphoma: description and analysis by laser capture microdissection","volume":"99","author":"Cong","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.humpath.2024.105676_bib45","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3324\/haematol.2013.085506","article-title":"Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies","volume":"98","author":"Pillai","year":"2013","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.humpath.2024.105676_bib46","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/his.14535","article-title":"In-situ follicular neoplasia: a clinicopathological spectrum","volume":"79","author":"Tamber","year":"2021","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.humpath.2024.105676_bib47","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2011-05-355255","article-title":"Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma","volume":"118","author":"Jegalian","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.humpath.2024.105676_bib48","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1182\/blood-2011-07-368944","article-title":"A unique case of follicular lymphoma provides insights to the clonal evolution from follicular lymphoma in situ to manifest follicular lymphoma","volume":"118","author":"Bonzheim","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.humpath.2024.105676_bib49","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.3324\/haematol.2020.254854","article-title":"Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype","volume":"106","author":"Vogelsberg","year":"2021","journal-title":"Haematologica"},{"issue":"Suppl 2","key":"10.1016\/j.humpath.2024.105676_bib50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00292-021-01011-x","article-title":"Die genetische Evolution der in situ follikul\u00e4ren Neoplasie zum t(14;18)-positiven aggressiven B-Zell-Lymphom [Genetic evolution of in situ follicular neoplasia to t(14;18)-positive aggressive B-cell lymphoma]","volume":"42","author":"Vogelsberg","year":"2021","journal-title":"Pathologe"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib51","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1309\/AJCP5RT4MRSDGKSX","article-title":"Coexisting follicular and mantle cell lymphoma with each having an in situ component: a novel, curious, and complex consultation case of coincidental, composite, colonizing lymphoma","volume":"133","author":"Roullet","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"22","key":"10.1016\/j.humpath.2024.105676_bib52","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood.2019000012","article-title":"Follicular lymphoma with composite in situ mantle cell neoplasia","volume":"133","author":"Subtil","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.humpath.2024.105676_bib53","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000000628","article-title":"Incidental and isolated follicular lymphoma in situ and mantle cell lymphoma in situ lack clinical significance","volume":"40","author":"Bermudez","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/cup.12409","article-title":"CD8-positive peripheral T-cell lymphoma with aberrant expression of CD20 and concurrent in situ follicular lymphoma","volume":"42","author":"Sagasta","year":"2015","journal-title":"J Cutan Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105676_bib55","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3324\/haematol.2013.094474","article-title":"Early lesions of follicular lymphoma: a genetic perspective","volume":"99","author":"Mamessier","year":"2014","journal-title":"Haematologica"},{"issue":"25","key":"10.1016\/j.humpath.2024.105676_bib56","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1182\/blood-2018-03-837039","article-title":"CREBBP gene mutations are frequently detected in in situ follicular neoplasia","volume":"132","author":"Schmidt","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib57","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3324\/haematol.2020.249342","article-title":"Lack of activation-induced cytidine deaminase expression in in situ follicular neoplasia","volume":"106","author":"Goyal","year":"2021","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib58","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/sj.leu.2403323","article-title":"Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL","volume":"18","author":"Hardianti","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.105676_bib59","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.humpath.2017.08.024","article-title":"Follicular lymphoma with hyaline-vascular Castleman-like features: analysis of 6 cases and review of the literature","volume":"68","author":"Pina-Oviedo","year":"2017","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2024.105676_bib60","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/1097-0142(19811015)48:8<1794::AID-CNCR2820480817>3.0.CO;2-M","article-title":"Morphologic criteria for the differentiation of follicular lymphoma from florid reactive follicular hyperplasia: a study of 80 cases","volume":"48","author":"Nathwani","year":"1981","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.humpath.2024.105676_bib61","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/modpathol.2009.106","article-title":"Diffuse blastoid B-cell lymphoma: a histologically aggressive variant of t(14;18)-negative follicular lymphoma","volume":"22","author":"Chiu","year":"2009","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105676_bib62","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0046-8177(99)90003-5","article-title":"Clinical significance of follicular lymphoma with monocytoid B cells. Non-Hodgkin's Lymphoma Classification Project","volume":"30","author":"Nathwani","year":"1999","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2024.105676_bib63","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/labinvest.3780169","article-title":"Follicular lymphoma with monocytoid B-cell proliferation: molecular assessment of the clonal relationship between the follicular and monocytoid B-cell components","volume":"80","author":"Robetorye","year":"2000","journal-title":"Lab Invest"},{"issue":"3","key":"10.1016\/j.humpath.2024.105676_bib64","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/ajcp\/88.3.264","article-title":"Follicular lymphoma mimicking progressive transformation of germinal centers","volume":"88","author":"Osborne","year":"1987","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105676_bib65","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1309\/UUEPLF2PHYXQDJNQ","article-title":"Follicular hyperplasia, follicular lysis, and progressive transformation of germinal centers. A sequential spectrum of morphologic evolution in lymphoid hyperplasia","volume":"120","author":"Chang","year":"2003","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2024.105676_bib66","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1600-0463.2006.apm_424.x","article-title":"Histological variety of floral variant of follicular lymphoma","volume":"114","author":"Kojima","year":"2006","journal-title":"APMIS"},{"key":"10.1016\/j.humpath.2024.105676_bib119","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/PAS.0000000000001399","article-title":"Unusual variants of follicular lymphoma","volume":"44","author":"Chapman","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib67","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41379-021-00938-z","article-title":"Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation","volume":"35","author":"Gibson","year":"2022","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105676_bib68","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00000478-197806000-00001","article-title":"Signet ring cell lymphoma. A rare morphologic and functional expression of nodular (follicular) lymphoma","volume":"2","author":"Kim","year":"1978","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105676_bib69","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.anndiagpath.2016.10.002","article-title":"Signet-ring cell lymphoma: clinicopathologic, immunohistochemical, and fluorescence in situ hybridization studies of 7 cases","volume":"26","author":"Zhang","year":"2017","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2024.105676_bib70","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1158\/2643-3230.BCD-21-0075","article-title":"Follicular lymphoma microenvironment characteristics associated with tumor cell mutations and MHC class II expression","volume":"3","author":"Han","year":"2022","journal-title":"Blood Cancer Discov"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib71","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/imr.12755","article-title":"Germinal center-derived lymphomas: the darkest side of humoral immunity","volume":"288","author":"Mlynarczyk","year":"2019","journal-title":"Immunol Rev"},{"issue":"9","key":"10.1016\/j.humpath.2024.105676_bib72","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/PAS.0b013e3181e9343d","article-title":"Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components","volume":"34","author":"Younes","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2024.105676_bib73","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/his.12076","article-title":"Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups","volume":"62","author":"Marafioti","year":"2013","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.humpath.2024.105676_bib74","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/PAI.0000000000000107","article-title":"Diagnostic utility of the germinal center-associated markers GCET1, HGAL, and LMO2 in hematolymphoid neoplasms","volume":"23","author":"Menter","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105676_bib75","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/PAS.0000000000001015","article-title":"Comparison of myocyte enhancer factor 2B versus other germinal center-associated antigens in the differential diagnosis of B-cell non-Hodgkin lymphomas","volume":"42","author":"Moore","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105676_bib76","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/path.1689","article-title":"Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation","volume":"205","author":"Schraders","year":"2005","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2024.105676_bib77","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/modpathol.2015.42","article-title":"CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases","volume":"28","author":"Li","year":"2015","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib78","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2559.2011.03779.x","article-title":"Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome","volume":"58","author":"Jin","year":"2011","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib79","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/modpathol.2016.214","article-title":"Epstein-Barr virus-positive follicular lymphoma","volume":"30","author":"Mackrides","year":"2017","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105676_bib80","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1002\/ajh.25357","article-title":"Prevalence, clinical characteristics and prognosis of EBV-positive follicular lymphoma","volume":"94","author":"Mackrides","year":"2019","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.humpath.2024.105676_bib81","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.3109\/10428194.2013.769218","article-title":"Epstein-Barr virus latent membrane protein 1 increases genomic instability through Egr-1-mediated up-regulation of activation-induced cytidine deaminase in B-cell lymphoma","volume":"54","author":"Kim","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"14","key":"10.1016\/j.humpath.2024.105676_bib82","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1614598","article-title":"Obinutuzumab for the first-line treatment of follicular lymphoma","volume":"377","author":"Marcus","year":"2017","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.humpath.2024.105676_bib83","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1200\/JCO.2017.76.8960","article-title":"Immunochemotherapy with obinutuzumab or rituximab for previously untreated follicular lymphoma in the GALLIUM study: influence of chemotherapy on efficacy and safety","volume":"36","author":"Hiddemann","year":"2018","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib84","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.3324\/haematol.2017.175059","article-title":"Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort","volume":"103","author":"Rimsza","year":"2018","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.humpath.2024.105676_bib85","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJMoa1805104","article-title":"Rituximab plus lenalidomide in advanced untreated follicular lymphoma","volume":"379","author":"Morschhauser","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.humpath.2024.105676_bib86","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international Consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.humpath.2024.105676_bib87","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1182\/blood.V99.10.3806","article-title":"Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3","volume":"99","author":"Ott","year":"2002","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.humpath.2024.105676_bib88","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3324\/haematol.2011.042531","article-title":"Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles","volume":"96","author":"Horn","year":"2011","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.humpath.2024.105676_bib89","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3324\/haematol.2017.181024","article-title":"Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2","volume":"103","author":"Horn","year":"2018","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.humpath.2024.105676_bib90","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/PAS.0000000000001726","article-title":"High-grade follicular lymphomas exhibit clinicopathologic, cytogenetic, and molecular diversity extending beyond grades 3A and 3B","volume":"45","author":"Laurent","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2024.105676_bib91","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3324\/haematol.2011.042531","article-title":"Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles","volume":"96","author":"Horn","year":"2011","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.humpath.2024.105676_bib92","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood-2006-09-045989","article-title":"CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features","volume":"109","author":"Karube","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.humpath.2024.105676_bib93","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4143\/crt.2018.190","article-title":"Radiation therapy outcome and clinical features of duodenal-type follicular lymphoma","volume":"51","author":"Lee","year":"2019","journal-title":"Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.humpath.2024.105676_bib94","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1349-7006.2011.01980.x","article-title":"Primary gastrointestinal follicular lymphoma involving the duodenal second portion is a distinct entity: a multicenter, retrospective analysis in Japan","volume":"102","author":"Takata","year":"2011","journal-title":"Cancer Sci"},{"issue":"11","key":"10.1016\/j.humpath.2024.105676_bib95","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1200\/JCO.2010.32.9193","article-title":"Primary follicular lymphoma of the duodenum is a distinct mucosal\/submucosal variant of follicular lymphoma: a retrospective study of 63 cases","volume":"29","author":"Schmatz","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib96","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/pin.12740","article-title":"Villous colonization (glove balloon sign): a histopathological diagnostic marker for follicular lymphomas with duodenal involvement including duodenal-type follicular lymphoma","volume":"69","author":"Tsuyama","year":"2019","journal-title":"Pathol Int"},{"issue":"9","key":"10.1016\/j.humpath.2024.105676_bib97","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.21873\/anticanres.16598","article-title":"Gastrointestinal follicular lymphoma: a single-institutional experience of 22 cases with emphasis on the comprehensive clinicopathological analysis and diagnostic Re-classification","volume":"43","author":"Oh","year":"2023","journal-title":"Anticancer Res"},{"issue":"16","key":"10.1016\/j.humpath.2024.105676_bib98","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood-2018-03-837252","article-title":"Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles","volume":"132","author":"Hellmuth","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib99","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/modpathol.2012.127","article-title":"Duodenal follicular lymphoma lacks AID but expresses BACH2 and has memory B-cell characteristics","volume":"26","author":"Takata","year":"2013","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0002-9440(10)63802-3","article-title":"Primary follicular lymphoma of the small intestine: alpha4beta7 expression and immunoglobulin configuration suggest an origin from local antigen-experienced B cells","volume":"162","author":"Bende","year":"2003","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2024.105676_bib101","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.4251\/wjgo.v14.i8.1552","article-title":"Duodenal-type follicular lymphoma more than 10 years after treatment intervention: a retrospective single-center analysis","volume":"14","author":"Saito","year":"2022","journal-title":"World J Gastrointest Oncol"},{"issue":"36","key":"10.1016\/j.humpath.2024.105676_bib102","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.18632\/oncotarget.26912","article-title":"Histological transformation in duodenal-type follicular lymphoma: a case report and review of the literature","volume":"10","author":"Tanigawa","year":"2019","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.humpath.2024.105676_bib103","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/jha2.384","article-title":"Clinical features and outcomes of duodenal-type follicular lymphoma: a single-center retrospective study","volume":"3","author":"Kamijo","year":"2022","journal-title":"EJHaem"},{"issue":"5","key":"10.1016\/j.humpath.2024.105676_bib104","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s12185-020-02957-z","article-title":"Development of diffuse large B-cell lymphoma from duodenal type follicular lymphoma: a retrospective study of 23 cases","volume":"112","author":"Saburi","year":"2020","journal-title":"Int J Hematol"},{"issue":"20","key":"10.1016\/j.humpath.2024.105676_bib105","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1182\/blood-2011-06-361972","article-title":"MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype","volume":"118","author":"Leich","year":"2011","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.humpath.2024.105676_bib106","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1182\/bloodadvances.2022009456","article-title":"The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas","volume":"7","author":"Salaverria","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2024.105676_bib107","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2559.2007.02678.x","article-title":"Significant high expression of CD23 in follicular lymphoma of the inguinal region","volume":"50","author":"Thorns","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2024.105676_bib108","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1309\/AJCP27YWLIQRAJPW","article-title":"CD23 expression in follicular lymphoma: clinicopathologic correlations","volume":"135","author":"Olteanu","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2024.105676_bib109","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105676_bib110","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.humpath.2024.105676_bib111","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/modpathol.2016.51","article-title":"Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36\/TNFRSF14 abnormalities, and STAT6 mutations","volume":"29","author":"Siddiqi","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.105676_bib112","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-020-0335-0","article-title":"CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma","volume":"10","author":"Xian","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.humpath.2024.105676_bib113","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1182\/bloodadvances.2022008355","article-title":"Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III\/IV","volume":"6","author":"Los-de Vries","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2024.105676_bib117","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/cancers15030785","article-title":"Follicular lymphoma in the 5th edition of the WHO-classification of haematolymphoid neoplasms-updated classification and new biological data","volume":"15","author":"Kurz","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2024.105676_bib118","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13000-024-01512-2","article-title":"Transformation of t(14;18)-negative follicular lymphoma to plasmablastic lymphoma: a case report with analysis of genetic evolution","volume":"19","author":"Lim","year":"2024","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2024.105676_bib121","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12185-020-02901-1","article-title":"Diffuse follicular lymphoma variant with a typical diagnostic pattern and an unusually aggressive clinical presentation","volume":"112","author":"Mart\u00edn-Moro","year":"2020","journal-title":"Int J Hematol"},{"key":"10.1016\/j.humpath.2024.105676_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153697","article-title":"STAT6 and phosphorylated STAT6 are differentially expressed in lymphomas","volume":"229","author":"Karpathiou","year":"2022","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2024.105676_bib123","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bjh.15041","article-title":"The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion","volume":"180","author":"Zam\u00f2","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2024.105676_bib125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1158\/2159-8290.CD-16-0975","article-title":"CREBBP inactivation promotes the development of HDAC3-dependent lymphomas","volume":"7","author":"Jiang","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.humpath.2024.105676_bib115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00292-023-01250-0","article-title":"[CD23 positive, BCL2 rearrangement-negative germinal centre lymphomas]","volume":"44","author":"Menter","year":"2023","journal-title":"Pathol. Heidelb. Ger."},{"key":"10.1016\/j.humpath.2024.105676_bib120","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1182\/blood.V126.23.3923.3923","article-title":"STAT6 is recurrently and significantly mutated in follicular lymphoma and enhances the IL-4 induced expression of membrane-bound and soluble CD23","volume":"126","author":"B\u00f6sl","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105676_bib124","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/s41375-022-01641-x","article-title":"PARP14 is a novel target in STAT6 mutant follicular lymphoma","volume":"36","author":"Mentz","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.105676_bib126","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cell.2016.08.032","article-title":"Loss of the HVEM tumor suppressor in lymphoma and restoration by modified CAR-T cells","volume":"167","author":"Boice","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2024.105676_bib141","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/PAS.0000000000002003","article-title":"Follicle center lymphoma (FCL) of the lower female genital tract (LFGT): a novel variant of primary cutaneous follicle center lymphoma (PCFCL)","volume":"47","author":"Saksena","year":"2023","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2024.105676_bib156","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2016-03-703819","article-title":"Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene","volume":"128","author":"Schmidt","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105676_bib114","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00428-022-03432-2","article-title":"Follicular lymphoma and marginal zone lymphoma: how many diseases?","volume":"482","author":"Laurent","year":"2023","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"10.1016\/j.humpath.2024.105676_bib128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/10428190701742472","article-title":"Frequency of BCL2 and BCL6 translocations in follicular lymphoma: relation with histological and clinical features","volume":"49","author":"D\u00edaz-Alderete","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2024.105676_bib129","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/pin.13223","article-title":"Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements","volume":"72","author":"Ikoma","year":"2022","journal-title":"Pathol Int"},{"key":"10.1016\/j.humpath.2024.105676_bib127","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1182\/blood-2012-10-464958","article-title":"BCL6 breaks occur at different AID sequence motifs in Ig-BCL6 and non-Ig-BCL6 rearrangements","volume":"121","author":"Lu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105676_bib136","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cam4.865","article-title":"Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: comparison with current classification and definition of prognostic markers","volume":"5","author":"Lucioni","year":"2016","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.humpath.2024.105676_bib152","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00428-015-1855-z","article-title":"Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4\/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia","volume":"468","author":"Quintanilla-Martinez","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2024.105676_bib180","doi-asserted-by":"crossref","unstructured":"Koch K, Richter J, Hanel C, Huttmann A, Duhrsen U, Klapper W. Follicular lymphoma grade 3B and diffuse large B-cell lymphoma present a histopathological and molecular continuum lacking features of progression\/ transformation. Haematologica 2022;107(9):2144\u20132153. doi: 10.3324\/haematol.2021.279351. PMID: 35021600; PMCID: PMC9425313.","DOI":"10.3324\/haematol.2021.279351"},{"key":"10.1016\/j.humpath.2024.105676_bib131","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/bloodadvances.2022009415","article-title":"Unraveling the genetics of transformed splenic marginal zone lymphoma","volume":"7","author":"Grau","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2024.105676_bib132","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/bjh.19064","article-title":"Guideline for the diagnosis and management of marginal zone lymphomas: a British Society of Haematology Guideline","volume":"204","author":"Walewska","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2024.105676_bib133","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/his.13015","article-title":"Recurrent mutations in genes involved in nuclear factor-\u03baB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications","volume":"70","author":"van den Brand","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2024.105676_bib134","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/DAD.0b013e318289b20e","article-title":"Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions","volume":"36","author":"Kempf","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2024.105676_bib135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/cup.13399","article-title":"Primary cutaneous vs secondary cutaneous follicular lymphomas: a comparative study focused on BCL2, CD10, and t(14;18) expression","volume":"46","author":"Servitje","year":"2019","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2024.105676_bib144","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/his.14378","article-title":"Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma","volume":"79","author":"Hamamoto","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2024.105676_bib145","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1097\/PAS.0b013e31822bd8a8","article-title":"Clinicopathologic and genetic characterization of follicular lymphomas presenting in the ovary reveals 2 distinct subgroups","volume":"35","author":"Ozsan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105676_bib137","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/DAD.0b013e318255dbae","article-title":"Clonal identity and differences in primary cutaneous B-cell lymphoma occurring at different sites or time points in the same patient","volume":"35","author":"Fujiwara","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2024.105676_bib138","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humpath.2020.09.014","article-title":"The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma","volume":"106","author":"Barasch","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2024.105676_bib139","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/bloodadvances.2020002469","article-title":"Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features","volume":"5","author":"Zhou","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2024.105676_bib140","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.jid.2019.04.005","article-title":"Acquired N-linked glycosylation motifs in B-cell receptors of primary cutaneous B-cell lymphoma and the normal B-cell repertoire","volume":"139","author":"Koning","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2024.105676_bib142","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1365-2141.2011.08659.x","article-title":"Primary lymphoma\u2010like lesions of the uterine cervix; sheep in wolves' clothing","volume":"153","author":"Dyer","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2024.105676_bib143","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/PAS.0b013e31817d7470","article-title":"Follicular lymphoma of the thyroid gland","volume":"33","author":"Bacon","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105676_bib146","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.3390\/curroncol28060407","article-title":"Low-grade primary splenic CD10-positive small B-cell lymphoma\/follicular lymphoma","volume":"28","author":"Abdulbaki","year":"2021","journal-title":"Curr. Oncol. Tor. Ont"},{"key":"10.1016\/j.humpath.2024.105676_bib147","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/PAS.0b013e318193fcef","article-title":"Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases","volume":"33","author":"Mollejo","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105676_bib148","article-title":"IGH\/BCL2 status better predicts clinico-pathological behavior in primary splenic follicular lymphoma than histological grade and other molecular markers","volume":"15","author":"Verghese","year":"2022","journal-title":"Clin. Pathol. Thousand Oaks Ventura Cty. Calif"},{"key":"10.1016\/j.humpath.2024.105676_bib149","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2559.2004.01804.x","article-title":"Extranodal follicular lymphoma: a clinicopathological and genetic analysis of 15 cases arising at non\u2010cutaneous extranodal sites","volume":"44","author":"Goodlad","year":"2004","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib150","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.3928\/01913913-20240517-01","article-title":"Pediatric-type follicular lymphoma of the conjunctiva in two adolescents","volume":"61","author":"Shabto","year":"2024","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"3","key":"10.1016\/j.humpath.2024.105676_bib178","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PAS.0b013e31826b9b57","article-title":"Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma","volume":"37","author":"Liu","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2024.105676_bib151","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1182\/blood-2015-12-682591","article-title":"Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations","volume":"128","author":"Louissaint","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105676_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1205384","article-title":"Case report: clinicopathological and molecular characteristics of pediatric-type follicular lymphoma","volume":"11","author":"Ren","year":"2023","journal-title":"Front Pediatr"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib154","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.path.2010.08.002","article-title":"Recent advances in follicular lymphoma: pediatric, extranodal, and follicular lymphoma in situ","volume":"3","author":"Ferry","year":"2010","journal-title":"Surg Pathol Clin"},{"issue":"6","key":"10.1016\/j.humpath.2024.105676_bib155","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00428-019-02681-y","article-title":"Novel markers in pediatric-type follicular lymphoma","volume":"475","author":"Agostinelli","year":"2019","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.humpath.2024.105676_bib157","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2017-03-776278","article-title":"Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation","volume":"130","author":"Schmidt","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.humpath.2024.105676_bib158","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/modpathol.2016.102","article-title":"A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma","volume":"29","author":"Ozawa","year":"2016","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2024.105676_bib159","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.3324\/haematol.2018.211631","article-title":"A high definition picture of key genes and pathways mutated in pediatric follicular lymphoma","volume":"104","author":"Lovisa","year":"2019","journal-title":"Haematologica"},{"issue":"16","key":"10.1016\/j.humpath.2024.105676_bib160","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1182\/bloodadvances.2022007322","article-title":"A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile","volume":"6","author":"Salmeron-Villalobos","year":"2022","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.humpath.2024.105676_bib161","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00428-023-03493-x","article-title":"Comparison of histological and molecular features of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma","volume":"482","author":"Lee","year":"2023","journal-title":"Virchows Arch"},{"issue":"10","key":"10.1016\/j.humpath.2024.105676_bib162","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/PAS.0000000000001932","article-title":"Pediatric-type indolent B-cell lymphomas with overlapping clinical, pathologic, and genetic features","volume":"46","author":"Lim","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib163","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","article-title":"Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults","volume":"118","author":"Salaverria","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.humpath.2024.105676_bib165","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1182\/bloodadvances.2021006034","article-title":"Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements","volume":"6","author":"Frauenfeld","year":"2022","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.humpath.2024.105676_bib166","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.14885","article-title":"Reclassification of diffuse large B cell lymphoma to large B cell lymphoma with IRF4 rearrangement in an adult population","volume":"82","author":"Hesius","year":"2023","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.humpath.2024.105676_bib167","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00428-023-03689-1","article-title":"Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes","volume":"484","author":"Pizzi","year":"2024","journal-title":"Virchows Arch"},{"issue":"5","key":"10.1016\/j.humpath.2024.105676_bib168","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.immuni.2013.04.009","article-title":"Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4","volume":"38","author":"Ochiai","year":"2013","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.humpath.2024.105676_bib169","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/pin.13067","article-title":"B cell lymphoma with IRF4 rearrangement: a clinicopathological study of 13 cases","volume":"71","author":"Zhou","year":"2021","journal-title":"Pathol Int"},{"issue":"3","key":"10.1016\/j.humpath.2024.105676_bib170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00428-023-03590-x","article-title":"Emerging entities: high-grade\/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP\/SH lymphoma workshop","volume":"483","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib164","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","article-title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","volume":"135","author":"Ramis-Zaldivar","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.humpath.2024.105676_bib171","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","article-title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","volume":"135","author":"Ramis-Zaldivar","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib172","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/MPH.0b013e31820e4636","article-title":"Primary follicular lymphoma of the testis in children and adolescents","volume":"34","author":"Lones","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105676_bib173","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00043426-200402000-00007","article-title":"Primary follicular lymphoma of the testis: excellent outcome following surgical resection without adjuvant chemotherapy","volume":"26","author":"Heller","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"10.1016\/j.humpath.2024.105676_bib174","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1626::AID-CNCR27>3.0.CO;2-0","article-title":"Primary follicular lymphoma of the testis in childhood","volume":"85","author":"Finn","year":"1999","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.humpath.2024.105676_bib175","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/jcp.55.9.684","article-title":"Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics","volume":"55","author":"Pileri","year":"2002","journal-title":"J Clin Pathol"},{"issue":"7","key":"10.1016\/j.humpath.2024.105676_bib176","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/PAS.0b013e31802ee4ab","article-title":"Primary follicular lymphoma of the testis and epididymis in adults","volume":"31","author":"Bacon","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2024.105676_bib177","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0022-5347(05)64897-5","article-title":"Follicular large cell lymphoma localized to the testis in children","volume":"168","author":"Pakzad","year":"2002","journal-title":"J Urol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724001850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724001850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T21:41:47Z","timestamp":1741297307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817724001850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":178,"alternative-id":["S0046817724001850"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105676","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging clinicopathologic features and genetics in follicular lymphoma: Towards enhanced diagnostic accuracy and subtype differentiation","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105676"}}